On June 13, 2026 Principal, Ms. Pauli Wongspoke at the “Entrepreneurial Workshop,” an elective course under the Master of Technology Entrepreneurship program at the Hong Kong Polytechnic University (PolyU).

Invited as the course's external expert, Pauli shared her extensive expertise with an audience of approximately 35 aspiring tech entrepreneurs, primarily from mainland China.

The interactive session focused on the highly relevant topic “如何运用专利构建科技企业的护城河” (How to Use Patents to Build a Moat for Tech Enterprises).” Drawing from her deep background in patent drafting and global prosecution, Pauli provided real-world case studies, strategic advice, and practical insights on how startups can effectively leverage intellectual property as a defensive moat to protect their tech innovations and scale their businesses safely.

我们的过去活动

Recommended Insights

Is “Comparable” the New “Unexpected”? China’s SPC Relaxes Inventive Step Standard for Breakthrough Therapeutics

2026年7月14日
How the Supreme People's Court Established a New Benchmark for Unexpected Technical Effects in a Landmark Diabetic Nephropathy Case Proving inventive step for pharmaceutical compounds, especially a second medical use, remains one of the most challenging aspects of patent prosecution in China. When the prior art discloses a compound's general therapeutic properties, how can an […]

A Detailed Dive into China’s New Patent Term Extension Provisions

2020年12月11日
This article is a part of a larger article that highlights the newest draft implementation rules of the new Chinese Patent Law. This particular article takes a detailed dive into the patent term extension/adjustment provisions. One of the biggest and most exciting provisions in the newly amended patent law is patent term extension for delay […]

China Releases Draft Implementation Guidelines for the Drug Administration Law

2022年6月2日
The latest draft implementation guidelines for China’s Drug Administration Law (“Guidelines”) are out and open for comment. Previously, the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage Measures”) came into effect on July 4, 2021. The Guidelines indicate that the final approval of generic chemical drug applications for marketing approval […]

How to Protect a Crystal Form (Polymorph) Patent in China

2025年6月4日
Crystalline forms are critical to pharmaceutical patents, offering extended protection for improved stability, bioavailability, or manufacturability. However, securing such patents in China has grown increasingly difficult due to the China National Intellectual Property Administration (CNIPA)’s strict patentability criteria. Unlike the U.S. or Europe, where structural novelty or problem-solving utility may suffice, China demands quantifiable evidence of […]
Top crossarrow-right